Echo45 Advisors’s AbbVie ABBV Stock Holding History

Echo45 Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$221K	Buy	+843	New	+$216K	0.1%	107
2026 Q2	–	Sell	-963	Closed	-$209K	–	79
2026 Q1	$209K	Sell	963 -13	-1%	-$2.88K	0.12%	69
2025 Q4	$223K	Sell	976 -144	-13%	-$32.8K	0.13%	68
2025 Q3	$259K	Buy	+1,120	New	+$228K	0.15%	44
2025 Q2	–	Sell	-1,198	Closed	-$251K	–	53
2025 Q1	$251K	Sell	1,198 -157	-12%	-$30.5K	0.17%	44
2024 Q4	$246K	Buy	+1,355	New	+$249K	0.16%	45

Other funds holding ABBV

HCM

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Echo45 Advisors's ABBV Position: Q3 2026 in Review

Echo45 Advisors opened a new position in AbbVie (ABBV) in Q3 2026: 843 shares worth $221K. The stake represents 0.1% of the portfolio and ranks #107 among its holdings. This is a return to the name: Echo45 Advisors previously reported a position in ABBV as recently as Q1 2026.

Echo45 Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $259K in Q3 2025. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Echo45 Advisors held 843 shares of AbbVie worth $221K as of Q3 2026.
AbbVie was a new Echo45 Advisors position in Q3 2026.
AbbVie made up 0.1% of Echo45 Advisors's portfolio in Q3 2026, its #107 holding.
Echo45 Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Echo45 Advisors's AbbVie position peaked at $259K in Q3 2025.
246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Echo45 Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.